NOXCIN-400 is a fluoroquinolone antibiotic used to treat various bacterial infections, most commonly urinary tract infections (UTIs), prostate infections (prostatitis), and certain types of infectious diarrhea.
Noxcin-400 is a potent antibiotic formulation featuring Norfloxacin Tablets IP at a strength of 400 mg. As a member of the fluoroquinolone class of antibiotics, it is specifically designed to combat a wide range of bacterial infections. By inhibiting the DNA replication process of harmful bacteria, Noxcin-400 provides a reliable and fast-acting solution for patients suffering from acute infections, ensuring a quicker recovery and preventing the further spread of bacteria within the body.
This medication is widely recognized for its efficacy in treating urinary tract infections (UTIs), including complicated and uncomplicated cases. In addition to respiratory and urological health, Noxcin-400 is frequently prescribed for gastrointestinal infections, such as traveler?s diarrhea and certain types of gastroenteritis. Its broad-spectrum activity makes it a versatile tool for healthcare professionals in managing infections that affect the urinary system, prostate, and digestive tract.
Noxcin-400 is formulated to provide optimal bioavailability, ensuring that the active ingredient is absorbed efficiently for maximum therapeutic impact. The 400 mg dosage is balanced to provide strong antibacterial action while maintaining a manageable safety profile for adult patients. It is an essential component of any pharmaceutical antibiotic range, valued for its consistent clinical performance in clearing stubborn infections that may be resistant to other classes of antimicrobial agents.
Marketed by MK Healthcare, Noxcin-400 is manufactured in facilities that adhere to global quality standards, including ISO and WHO-GMP certifications. The tablets are supplied in high-quality 10x10 blister packaging to ensure long-term stability and protection against environmental factors. MK Healthcare offers Noxcin-400 as part of its extensive PCD pharma franchise and third-party manufacturing portfolio, providing business partners with a high-demand, high-quality antibiotic product.
